Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. NAFLD stages range from simple steatosis (NAFL) to non-alcoholic …

Background Non-alcoholic fatty liver disease (NAFLD), characterized as excess lipid
accumulation in the liver which is not due to alcohol use, has emerged as one of the major …

The initial presentation of non-alcoholic steatohepatitis (NASH) is hepatic steatosis. The
dysfunction of lipid metabolism within hepatocytes caused by genetic factors, diet, and …

Nonalcoholic fatty liver disease (NAFLD)–induced hepatocellular carcinoma (HCC) is an
emerging malignancy in the developed world; however, mechanisms that contribute to its …

N6-methyladenosine (m 6 A) mRNA modification plays critical roles in various biological
events and is involved in multiple complex diseases. However, the role of m 6 A modification …

Autophagy, which is tightly regulated by a series of autophagy-related genes (ATGs), is a
vital intracellular homeostatic process through which defective proteins and organelles are …

Background Autophagy, a process for degrading intracellular substances to maintain basal
metabolic turnover, is known to be perturbed in gastric cancer. Programmed cell death-1 …

Sepsis and septic shock driven by microbial infections are still among the most challenging
health problems, causing 11 million deaths worldwide every year. How does the host's …

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases
with a global rising prevalence, which is closely associated with a high-fat diet (HFD) intake …

Lipid droplet is a dynamic organelle that undergoes periods of biogenesis and degradation
under environmental stimuli. The excessive accumulation of lipid droplets is the major …